13 Mar Iron and Iron Proteins in Breast Cancer Development and Prognosis – Christopher R. Chitambar, MD
When:
May 20, 2015 @ 12:00 pm – 1:00 pm
2015-05-20T12:00:00-05:00
2015-05-20T13:00:00-05:00
Where:
Froedtert - Dynacare Lab Building, 2nd floor, Ob-Gyn conference room #252
Contact:
Presented by
Christopher R. Chitambar, MD
Christopher R. Chitambar, MD
Professor of Medicine
Director, Hematology/Oncology Fellowship Program
Division of Hematology & Oncology
Medical College of Wisconsin and Froedtert Clinical Cancer Center
About Dr. Chitambar
Dr. Chitambar’s research focuses on understanding the role of iron proteins in tumor cell growth, apoptosis, oxidative stress, and mitochondrial function, with a particular emphasis on the development of novel gallium compounds as therapeutic agents. His clinical emphasis is on the treatment of patients with breast cancer and lymphoma and the development of clinical trials for these diseases.